- Home
- CHRO vs FTEL Comparison
CHRO vs FTEL Comparison
Compare CHRO & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRO
- FTEL
- Stock Information
- Founded
- CHRO 2002
- FTEL 2007
- Country
- CHRO United States
- FTEL Australia
- Employees
- CHRO N/A
- FTEL N/A
- Industry
- CHRO
- FTEL
- Sector
- CHRO
- FTEL
- Exchange
- CHRO Nasdaq
- FTEL Nasdaq
- Market Cap
- CHRO 8.4M
- FTEL 9.6M
- IPO Year
- CHRO 2024
- FTEL 2023
- Fundamental
- Price
- CHRO $0.95
- FTEL $0.54
- Analyst Decision
- CHRO Strong Buy
- FTEL
- Analyst Count
- CHRO 1
- FTEL 0
- Target Price
- CHRO N/A
- FTEL N/A
- AVG Volume (30 Days)
- CHRO 2.1M
- FTEL 110.4K
- Earning Date
- CHRO 05-13-2025
- FTEL 05-27-2025
- Dividend Yield
- CHRO N/A
- FTEL N/A
- EPS Growth
- CHRO N/A
- FTEL N/A
- EPS
- CHRO N/A
- FTEL N/A
- Revenue
- CHRO N/A
- FTEL $4,990,695.00
- Revenue This Year
- CHRO N/A
- FTEL N/A
- Revenue Next Year
- CHRO N/A
- FTEL N/A
- P/E Ratio
- CHRO N/A
- FTEL N/A
- Revenue Growth
- CHRO N/A
- FTEL 29.02
- 52 Week Low
- CHRO $0.45
- FTEL $0.43
- 52 Week High
- CHRO $3.80
- FTEL $49.50
- Technical
- Relative Strength Index (RSI)
- CHRO 35.68
- FTEL 40.21
- Support Level
- CHRO $0.91
- FTEL $0.48
- Resistance Level
- CHRO $1.14
- FTEL $0.54
- Average True Range (ATR)
- CHRO 0.12
- FTEL 0.06
- MACD
- CHRO -0.01
- FTEL 0.03
- Stochastic Oscillator
- CHRO 17.04
- FTEL 53.20
About CHRO Chromocell Therapeutics Corporation
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
About FTEL Fitell Corporation
Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.